CD4 and neoplasm: Indeed, PD-1high CD4+ T cells isolated from MMRd ECs co-expressed other activation markers such as CD38, HLA-DR, ICOS, BCL6, CXCL13 and KI67, were proven to be tumor-reactive T cells and correlated with improved prognosis in ECs with high TMB (160).